A genome-wide pleiotropy study between atopic dermatitis and neuropsychiatric disorders DOI Creative Commons
Charalabos Antonatos, Alexandros Pontikas,

Adam Akritidis

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 30, 2024

Abstract Comorbidities between atopic dermatitis (AD) and neuropsychiatric disorders are frequently reported, however the extent of shared genetic architecture remains unclear. Here, we performed a large-scale genome-wide pleiotropy approach to investigate correlations causal associations AD five disorders, attention deficit hyperactivity disorder (ADHD), autism spectrum (ASD), bipolar (BP), major depressive (MDD), schizophrenia (SCZ). Using association (GWAS) data, explored overlaps, pleiotropic loci assessed capacity identify drug targets. We identified significant positive ADHD (rg=0.14, P-value=2×10), MDD (rg=0.13, P-value=1.2×10 ³) BP (rg=0.11, P-value= 4×10 ³). Genome-wide scans 37 distinct traits, with gene-based analyses highlighting 86 unique genes participating in inflammatory pathways. Pleiotropy-informed target prioritization facilitated identification novel pathophysiological mechanisms for putative targets, such as members TNF JAK-STAT3 signaling. Mendelian randomization provided evidence relationship liability an increased risk AD, independent sample overlap. Collectively, our findings elucidate molecular emphasizing immune-related pathways key contributors both disease categories, potential implications therapeutic interventions targeting common mechanisms.

Language: Английский

Atopic dermatitis DOI
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner

et al.

The Lancet, Journal Year: 2025, Volume and Issue: 405(10478), P. 583 - 596

Published: Feb. 1, 2025

Language: Английский

Citations

3

Skin Barrier in Atopic Dermatitis DOI
Matthias Schmuth,

Sonja Eckmann,

Verena Moosbrugger‐Martinz

et al.

Journal of Investigative Dermatology, Journal Year: 2024, Volume and Issue: 144(5), P. 989 - 1000.e1

Published: April 19, 2024

Language: Английский

Citations

12

An S100A8/A9 neutralizing antibody potently ameliorates contact hypersensitivity and atopic dermatitis symptoms. DOI Creative Commons

Yuma Gohara,

Rie Kinoshita, Nahoko Tomonobu

et al.

Journal of Investigative Dermatology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

1

Update on the pathogenesis of atopic dermatitis DOI Creative Commons
Paulo Ricardo Criado, Hélio Amante Miot, Roberto Bueno Filho

et al.

Anais Brasileiros de Dermatologia, Journal Year: 2024, Volume and Issue: 99(6), P. 895 - 915

Published: Aug. 12, 2024

Atopic dermatitis is a chronic, recurrent, and multifactorial skin-mucosal manifestation resulting from the interaction between elements mainly associated with skin barrier deficit, homeostasis of immune response, neurological aspects, patterns reactivity to environmental antigens, which are established in genetically predisposed individuals. In addition skin, atopic diathesis involves other organs such as airways (upper lower), eyes, digestive tract, neuropsychiatric inflict additional morbidity on dermatological patient. The different phenotypes disease fundamentally depend participation each these factors, life circumstances, age groups, occupational exposure patterns, physical activity, pollution, genetic load, climatic factors. A better understanding complexity its pathogenesis allows not only therapeutic targets but also how identify preponderant that mediate activity circumstance, for selecting best treatment strategies mitigation triggering This narrative review presents an update dermatitis, especially aimed at clinical manifestations, main context available strategies.

Language: Английский

Citations

5

Off-Label Treatment in Inflammatory Skin Diseases—European Point of View DOI Open Access

Julia Sternicka,

Roman Nowicki, Leszek Bieniaszewski

et al.

Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(7), P. 2376 - 2376

Published: March 30, 2025

Off-label treatment is the use of a drug approved for marketing, outside registration in terms indication, age group, dose or route administration. Despite constant appearance new preparations on market, SmPCs guidelines current clinical problem. It believed that it based needs patients unmet by classical therapy methods. This work focuses off-label inflammatory dermatoses such as atopic dermatitis, psoriasis, acne vulgaris and rosacea. Publications this subject, available PubMed, Google Scholar Cochrane Library, were analyzed form review, taking into account mechanisms action, efficacy safety preparations. Based literature analysis, can be concluded drugs SmPC indications common situation dermatology. However, difficult to determine its exact frequency-there lack data prevalence appliances from European perspective. demonstrate varying effectiveness therapy, depending specific preparation. dermatology remains an important issue should explored further research.

Language: Английский

Citations

0

Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitis DOI Creative Commons
Meritxell Oliva, Mrinal K. Sarkar, Michael March

et al.

Nature Communications, Journal Year: 2025, Volume and Issue: 16(1)

Published: April 1, 2025

Atopic dermatitis is a highly heritable and common inflammatory skin condition affecting children adults worldwide. Multi-ancestry approaches to atopic genetic association studies are poised boost power detect signal identify loci contributing risk. Here, we present multi-ancestry GWAS meta-analysis of twelve cohorts from five ancestral populations totaling 56,146 cases 602,280 controls. We report 101 genomic associated with dermatitis, including 16 that have not been previously or eczema. Fine-mapping, QTL colocalization, cell-type enrichment analyses identified genes cell types implicated in pathophysiology. Functional keratinocytes provide evidence for could play role through epidermal barrier function. Our study provides insights into the etiology by harnessing multiple functional unveil mechanisms which dermatitis-associated variants impact types. condition. authors perform carry out downstream experiments understand they identify.

Language: Английский

Citations

0

Difamilast Topically Ameliorates Pruritus, Dermatitis, and Barrier Dysfunction in Atopic Dermatitis Model Mice by Inhibiting Phosphodiesterase 4, Especially the 4B Subtype. DOI

Kazuyoshi Kirima,

Yukio Hoshino,

Naoya Arichika

et al.

Journal of Pharmacology and Experimental Therapeutics, Journal Year: 2025, Volume and Issue: unknown, P. 103582 - 103582

Published: April 1, 2025

Language: Английский

Citations

0

Deciphering epigenetic regulations in the inflammatory pathways of atopic dermatitis DOI
Alberto José da Silva Duarte, Sabri Saeed Sanabani

Life Sciences, Journal Year: 2024, Volume and Issue: 348, P. 122713 - 122713

Published: May 11, 2024

Language: Английский

Citations

3

Extracellular Vesicles and Their Role in Skin Inflammatory Diseases: From Pathogenesis to Therapy DOI Open Access
Lei Xuan, Sabine Ring,

Shiying Jin

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(8), P. 3827 - 3827

Published: April 18, 2025

Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, are released into the extracellular space by almost all known cell types. They facilitate communication between cells transferring bioactive molecules, which impact both physiological processes development of diseases. EVs play a crucial role in pathogenesis various diseases participating multiple pathological processes. contribute to disease progression triggering cytokine release, modulating immune activity, inducing inflammatory responses. Beyond their implications, also offer significant therapeutic potential. Both natural engineered show great potential fields targeted therapy, drug delivery, modulation dermatological applications. The EV-based treatments is showing promise advancing patient outcomes, particularly chronic immune-mediated skin conditions. This review comprehensively examined biogenesis, classification, functional roles EVs, advanced methods for isolation characterization. Furthermore, we summarized recent studies highlighting involvement four major diseases: psoriasis, atopic dermatitis, systemic lupus erythematosus, wound healing.

Language: Английский

Citations

0

Gut microbiota modulation: a key determinant of atopic dermatitis susceptibility in children DOI Creative Commons

Huimiao Tang,

Wenxin Li, Yidan Xu

et al.

Frontiers in Microbiology, Journal Year: 2025, Volume and Issue: 16

Published: April 28, 2025

Atopic dermatitis is a chronic inflammatory skin condition with higher incidence rate among children. In recent years, the role of gut microbiota in pathogenesis atopic has garnered increasing attention. This review systematically delineates research advancements structural characteristics children and its influencing factors. Studies have revealed significant differences structure between healthy controls, characterized by reduction microbial diversity, decrease beneficial bacteria, an increase harmful bacteria. Dietary patterns, environmental factors, birth antibiotic use, gestational diabetes mellitus are factors could impact hence susceptibility to dermatitis. Moreover, this explores interplay immune system dermatitis, potential inform more effective probiotic treatment strategies for

Language: Английский

Citations

0